ALK and neoplasm: Therefore, modified study designs (eg, single-arm basket or umbrella studies) are needed to generate meaningful data for tumor types with rare molecular alterations.26,27 Evidence suggests that ALK inhibitors may be efficacious across different indications3,28 and there is a need for further investigations of the clinical value of ALK TKIs in a tumor-agnostic way.